Skip to content
Screener

Beta Bionics BBNX Inventories

Inventories at other companies

Insulet logo
InsuletPODD
$484.8M+8.5%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$135.11M-5.2%
Medtronic logo
MedtronicMDT
$5.95B+8.7%
Embecta Corp. logo
Embecta Corp.EMBC
$214.2M+12.8%
AdaptHealth logo
AdaptHealthAHCO
$159.27M+23.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$14.84M-53.7%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Reported directly by Beta Bionics in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777
Line itemJune 30,2026December 31,2025
Restricted cash, current100100
Short-term investments136,171187,549
Accounts receivable, net18,05317,118
Inventories23,91821,722
Prepaid expenses and other current assets8,4749,840
Total current assets231,034267,905
Property and equipment, net10,7488,600
Operating lease right-of-use asset5,8166,627

Item 1. Financial Statements.

FAQ

What is Beta Bionics's inventories?
Beta Bionics (BBNX) reported inventories of $23.92M in Q2 2026.
How has Beta Bionics's inventories changed year-over-year?
Beta Bionics's inventories increased by 38.1% year-over-year, from $17.32M to $23.92M.
What is the long-term trend for Beta Bionics's inventories?
Over 2 years (2023 to 2025), Beta Bionics's inventories has grown at a 493.2% compound annual growth rate (CAGR), from $2.14M to $75.15M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Ask your AI about Beta Bionics's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude